statistiche ricercatore

Continente	#
EU - Europa	732
NA - Nord America	549
AS - Asia	338
SA - Sud America	25
OC - Oceania	8
AF - Africa	1
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.654

Nazione	#
US - Stati Uniti d'America	521
DE - Germania	167
CN - Cina	154
GB - Regno Unito	150
IT - Italia	95
SE - Svezia	92
SG - Singapore	69
NL - Olanda	61
FR - Francia	43
RU - Federazione Russa	41
TR - Turchia	37
CA - Canada	28
BR - Brasile	20
IN - India	15
IE - Irlanda	14
PL - Polonia	14
BE - Belgio	13
JP - Giappone	13
EU - Europa	12
FI - Finlandia	12
KR - Corea	12
ID - Indonesia	11
UA - Ucraina	10
AU - Australia	8
HK - Hong Kong	8
DK - Danimarca	7
UZ - Uzbekistan	6
CH - Svizzera	4
CO - Colombia	4
JO - Giordania	3
RO - Romania	3
TW - Taiwan	3
GR - Grecia	2
KW - Kuwait	2
NO - Norvegia	2
PH - Filippine	2
A2 - ???statistics.table.value.countryCode.A2???	1
AT - Austria	1
BD - Bangladesh	1
CL - Cile	1
DZ - Algeria	1
KG - Kirghizistan	1
MD - Moldavia	1
VN - Vietnam	1
Totale	1.666

Nome	#
Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne Muscular Dystrophy	276
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy	210
A case report with the peculiar concomitance of 2 different genetic syndromes	210
New missense variants of NDUFA11 associated with late-onset myopathy	187
Combining Stem Cell and Exon Skipping Approach to Treat Muscular Dystrophies	175
Quantitative muscle strength assessment in Duchenne muscular dystrophy: longitudinal study and correlation with functional measures	164
MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form	147
Outcome measures validation study for mesoangioblasts transplantation in children affected by Duchenne Muscular Dystrophy	103
Quantitative muscle strength assessment in Duchenne Muscular Dystrophy : longitudinal study and correlation with functional measures	96
Effect of rituximab in two patients with dysferlin-deficient muscular dystrophy	89
Immune-mediated necrotizing myopathy due to statins exposure	83
Totale	1.740

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	24	0	0	0	0	0	0	0	0	0	0	8	16
2020/2021	160	7	8	2	16	6	6	19	19	21	13	29	14
2021/2022	162	15	10	4	6	13	21	5	7	24	11	19	27
2022/2023	261	51	33	24	25	21	44	7	18	15	3	9	11
2023/2024	137	4	10	12	10	27	5	14	8	1	10	12	24
2024/2025	251	17	22	8	47	22	11	7	28	17	60	12	0
Totale													1.740

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca